Traders Sell Envision Healthcare (EVHC) on Strength (EVHC)

Investors sold shares of Envision Healthcare Co. (NYSE:EVHC) on strength during trading on Wednesday. $6.31 million flowed into the stock on the tick-up and $36.45 million flowed out of the stock on the tick-down, for a money net flow of $30.14 million out of the stock. Of all stocks tracked, Envision Healthcare had the 19th highest net out-flow for the day. Envision Healthcare traded up $0.15 for the day and closed at $35.07

Several equities analysts have recently commented on the company. Stephens reiterated a “hold” rating and set a $34.00 target price on shares of Envision Healthcare in a research note on Wednesday. Robert W. Baird reduced their target price on Envision Healthcare from $70.00 to $35.00 and set an “outperform” rating for the company in a research note on Friday, November 3rd. Zacks Investment Research upgraded Envision Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. Oppenheimer reduced their target price on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating for the company in a research note on Thursday, November 2nd. Finally, KeyCorp set a $40.00 target price on Envision Healthcare and gave the company a “buy” rating in a research note on Tuesday, November 14th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $40.73.

The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. The stock has a market cap of $4,220.00, a PE ratio of -23.54, a PEG ratio of 1.00 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last issued its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. During the same period in the prior year, the business earned $1.13 earnings per share. Envision Healthcare’s quarterly revenue was up 142.0% on a year-over-year basis. analysts expect that Envision Healthcare Co. will post 2.49 EPS for the current fiscal year.

Envision Healthcare announced that its Board of Directors has authorized a stock buyback program on Monday, September 18th that authorizes the company to repurchase $250.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 4.5% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

A number of hedge funds and other institutional investors have recently modified their holdings of EVHC. Janus Henderson Group PLC increased its position in Envision Healthcare by 36,086.8% in the second quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock worth $247,239,000 after buying an additional 3,934,185 shares during the period. OZ Management LP acquired a new stake in Envision Healthcare in the third quarter worth $131,987,000. Maverick Capital Ltd. increased its position in Envision Healthcare by 66.2% in the second quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock worth $319,197,000 after buying an additional 2,028,026 shares during the period. Lord Abbett & CO. LLC increased its position in Envision Healthcare by 259.6% in the second quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock worth $82,808,000 after buying an additional 953,928 shares during the period. Finally, Westfield Capital Management Co. LP acquired a new stake in Envision Healthcare in the second quarter worth $45,892,000.

ILLEGAL ACTIVITY NOTICE: “Traders Sell Envision Healthcare (EVHC) on Strength (EVHC)” was published by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://www.com-unik.info/2018/01/10/traders-sell-envision-healthcare-evhc-on-strength-evhc.html.

Envision Healthcare Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

What are top analysts saying about Envision Healthcare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit